Medizinische Universitaet Innsbruck — Innsbruck

Public research footprint of Medizinische Universitaet Innsbruck, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Crohn's Disease · KRAS p.G12C Mutant Advanced Solid Tumors · Non Small Cell Lung Cancer · Atherosclerotic Cardiovascular Disease (ASCVD)

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT07007065 — Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and… (Recruiting)
NCT06459180 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Medizinische Universitaet Innsbruck?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.